Google DeepMind has introduced AlphaGenome, a new artificial intelligence model aimed at accelerating research in genetics and molecular biology. Built to analyze complex DNA sequences at scale, AlphaGenome is designed to help scientists better understand gene regulation, mutations and their links to disease. The launch reflects DeepMind’s expanding focus beyond protein structures toward broader genomic intelligence. As healthcare systems and biotech firms increasingly rely on data-driven discovery, AlphaGenome positions AI as a critical tool in reducing research timelines and costs.